1-2 of 2
Steve Devereux, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Bruton Tyrosine Kinase (Btk) Inhibitor ACP-196: Marked Activity in Relapsed/Refractory CLL with a Favorable Safety Profile

John C. Byrd, MD, William Wierda, MD PhD, Jeffrey Jones, MD MPH, Susan O'Brien, MD, Jennifer R. Brown, MD PhD, Anna Schuh, MD PhD, Peter Hillmen, MB, ChB, PhD, Deborah M. Stephens, DO, Paolo Ghia, MD PhD, Steve Devereux, MD, Jorge M. Chaves, MD, Jacqueline C. Barrientos, MD, Min Hui Wang, PhD, Jane Huang, MD, Todd Covey, Tasheda Navarro, Wayne Rothbaum, Raquel Izumi, PhD, Ahmed Hamdy, MBBCh, Richard R. Furman, MD
Journal: Blood
Blood (2015) 126 (23): 831.
https://doi.org/10.1182/blood.V126.23.831.831
Published: 2015
Journal Articles

Hematologic and Immunologic Function and Patient Well-Being for the Phase III RESONATE TM Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Jacqueline C. Barrientos, MD, Susan O'Brien, Jennifer R. Brown, MD PhD, Neil E. Kay, MD, Nishitha M. Reddy, MBBS, Steven Coutre, MD, Constantine Tam, MD, Stephen Mulligan, MBBS, MD FRACP, FRCPA, Ulrich Jaeger, MD, Steve Devereux, MD, Christopher Pocock, MD PhD, Tadeusz Robak, MD, Stephen J. Schuster, MD, Anna Schuh, MDPhD, Devinder Gill, MD, Adrian Bloor, PhD FRCPath, Claire Dearden, MD, Carol Moreno, MD, Gavin Cull, MBBS, DM, FRACP, FRCPA, Michael Hamblin, Jeffrey A. Jones, MD, Tanja Kierschniak, Karl Eckert, BA, Samuel Suzuki, MS, MBA, Emily Hsu, PhD, Danelle F. James, MD MAS, John C. Byrd, MD, Peter Hillmen, MB, ChB, PhD
Journal: Blood
Blood (2014) 124 (21): 4696.
https://doi.org/10.1182/blood.V124.21.4696.4696
Published: 2014